Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1842952 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $0.49 · Day −1.91% · Mkt cap $49M · 1Y −44.2% · Off 52W high −86.5% · Vol (1Y) 107.0% Price2023-08-21 → 2026-08-19 CNTX close: $1.02 on 2023-08-21 to $0.49 on 2026-08-19. Split-adj closes · 240 of 1,005 · price returnⓘ At a glance | Short interest6.3% of sh out | | Days to cover4.2d | | 13F net flow (QoQ)−1.94% | | Top-10 13F concentration79.6% | | Next report (est.)2026-11-04 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Earnings (TTM)-$46.0M | | ROE−46.4% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−66.8% | | 1Y−44.2% | | 3Y−52.2% | | Since incept. (ann.)−32.1% |
Total return · from 2021-12-17ⓘ Risk | Ann. volatility (1Y)107.0% | | Ann. volatility (3Y)97.4% | | Sharpe (1Y)0.06 | | Sharpe (3Y)0.23 | | Max drawdown (1Y)−86.5% | | Max drawdown (3Y)−86.5% | | Beta (3Y vs SPY)0.13 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| MPM BIOIMPACT LLC | 10.7M | $28M | 11.62% | +0.0% | | Avidity Partners Management LP | 10.0M | $25M | 10.88% | +81.6% | | Nextech Invest, Ltd. | 7.4M | $19M | 8.08% | +0.0% | | Deep Track Capital, LP | 7.4M | $19M | 8.08% | +0.0% | | Soleus Capital Management, L.P. | 7.0M | $18M | 7.58% | new | | Octagon Capital Advisors LP | 5.3M | $14M | 5.71% | new | | Blue Owl Capital Holdings LP | 5.1M | $13M | 5.54% | −31.5% | | FRANKLIN RESOURCES INC | 3.8M | $10M | 4.14% | −5.0% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-05 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-05 | −$0.15 | — | — | — | | 2026-03-31 | 2026-05-06 | −$0.09 | — | — | — | | 2025-09-30 | 2025-11-05 | −$0.10 | — | — | — | | 2025-06-30 | 2025-08-06 | −$0.09 | — | — | — |
As-reported XBRL · next 2026-11-04 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
